罕见病重症肌无力治疗破局：全球首款FcRn拮抗剂在中国上市

七印授权

2AQYQDC3HW96IPTR6904B20MZNMHXNPNSP7NNIHIQI7W8E9FI5

2023-09-06 09:45:09

article

5F5222A1B91F61FB949007088ACAD9E26B1530BE3E57AA0A5E4C2EC47CE63684

zh-CN

810C6AC3DBE42EC737C2BFAC2D1B6C124E284D4A

15203703

02636d79fc7c7cc37b9cb348037eec28743d030e5d570d0d69837a3587bed31880

6867d2c4b521e56952dbbf568df2d22e0e719d875215aa0bf44f3b212a93cdc22f5e3fda0de2a1c509c649e9f26cc11ac18d033f2750d05e6638ff903b62f5441b

{"parameters":{"adaptation":"n","price":"300000"},"type":"cm"}

yuanben_64f84a25b09343.45894253

原本认证

https://www.yuanben.io/article/e2ec4f67-bacc-4f11-85a6-26db6047197d

{"author":"每日经济新闻","authorization_pub_key":"03040cbbeae1adf91c3efd7306d09c6005403a041f9b7405dac489d4f8126fef8c"}